Biotech stocks are looking crowded, expert says

As the biotech sector and names such as Biogen continue to surge, finding value is becoming increasingly difficult, an expert says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.